Back

Sirolimus immunosuppressive therapy is associated with hypercholesterolemia and elevations in circulating PCSK9 levels

28 August 2016 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Best Posters session 3 - Best Posters in medical aspects of cardiac transplantation Medical aspects of transplantation ESC Premium Access ESC Congress 2016

About the speaker

Photo
Assistant Professor Vinaya Simha

Mayo Clinic, Rochester (United States of America)

4 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Doctor A. Sabashnikov (Harefield, GB)
Abstract Slides
Presentation thumbnail
Doctor E. Gutierrez Ibanes (Madrid, ES)
Abstract Slides
Presentation thumbnail
Doctor A. Capettini (Alessandria, IT)
Abstract Slides

Access the full session

Session thumbnail
Best Posters session 3 - Best Posters in medical aspects of cardiac transplantation

The Event

Event poster

ESC Congress 2016

28 August 2016 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Use of PCSK9 inhibitors for hypercholesterolemia treatment after heart transplant in a multicenter cohort
30 August 2025
thumbnail
Congress Presentation
Evolocumab rapidly reverses impaired coronary endothelial function in six weeks in people living with HIV and in patients with dyslipidemia
2 September 2019
thumbnail
Congress Presentation
Boosting secondary prevention: efficacy and adherence of inclisiran in post-acute coronary syndrome very high-risk patients
3 April 2025
thumbnail
Congress Presentation
Effects of PCSK9 inhibitor on adverse limb outcomes in patients with critical limb ischemia
28 August 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources